Suppr超能文献

临床综述126:促黄体生成素和促卵泡生成素在诱导排卵中的作用及新方案

Clinical review 126: Roles and novel regimens of luteinizing hormone and follicle-stimulating hormone in ovulation induction.

作者信息

Filicori M, Cognigni G E

机构信息

Reproductive Endocrinology Center, University of Bologna, 40138 Bologna, Italy.

出版信息

J Clin Endocrinol Metab. 2001 Apr;86(4):1437-41. doi: 10.1210/jcem.86.4.7385.

Abstract

Although FSH is universally recognized as the key driver of ovarian follicle growth and maturation, the role of LH in these processes is more controversial. LH acts on theca cells to induce androgen substrate for estrogen conversion by the aromatase system; furthermore, LH can affect granulosa cell function starting in the mid- follicular phase, when these cells express LH receptors. The capacity of LH to stimulate granulosa cells in larger follicles (>10 mm diameter) may be the critical mechanism involved in the selection of the dominant follicle in the normal menstrual cycle. Furthermore, the addition of LH activity can shorten and optimize FSH ovulation induction and reduce the development of smaller preovulatory ovarian follicles that are associated with the severe complications of this procedure. Novel mixed gonadotropin administration regimens that incorporate graded amounts of LH and FSH activity may improve efficacy, safety, and cost of ovulation induction, particularly in the area of assisted reproduction.

摘要

尽管促卵泡生成素(FSH)被公认为是卵巢卵泡生长和成熟的关键驱动因素,但促黄体生成素(LH)在这些过程中的作用更具争议性。LH作用于卵泡膜细胞,诱导雄激素底物,以供芳香化酶系统转化为雌激素;此外,从中卵泡期开始,当颗粒细胞表达LH受体时,LH会影响颗粒细胞功能。LH刺激较大卵泡(直径>10mm)中颗粒细胞的能力可能是正常月经周期中优势卵泡选择所涉及的关键机制。此外,添加LH活性可缩短并优化FSH诱导排卵的过程,并减少与该程序严重并发症相关的较小排卵前卵巢卵泡的发育。包含不同剂量LH和FSH活性的新型混合促性腺激素给药方案可能会提高诱导排卵的疗效、安全性和成本,特别是在辅助生殖领域。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验